We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Addex To Present at the Thirteenth London International Cough Symposium (13th LICS) Geneva, Switzerland, July 12, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage...
Addex Shareholders Approve All Resolutions at Annual General Meeting Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 1, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq:...
Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update ● GABAB PAM: Selection of drug candidates under Indivior collaboration expected by end of Q2 2024. Ad Hoc...
Addex Convenes Annual General Meeting 2024 Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 5, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage...
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024 Geneva, Switzerland, May 31, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage...
Addex to Present at Bio€quity Europe 2024 Geneva, Switzerland, May 8, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric...
Addex Provides Update on ADX71149 Phase 2 Epilepsy Study Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 29, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a...
Addex to Present at the Swiss Biotech Day 2024 Geneva, Switzerland, April 19, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 3.02 | 3.02 | 3.02 | 379 | 3.02 | DE |
12 | 0 | 0 | 3.02 | 3.02 | 3.02 | 9840 | 3.02 | DE |
26 | 0 | 0 | 3.02 | 3.02 | 3.02 | 18084 | 3.02 | DE |
52 | 0 | 0 | 3.02 | 3.02 | 3.02 | 16121 | 3.02 | DE |
156 | 0 | 0 | 3.02 | 3.02 | 3.02 | 19995 | 3.02 | DE |
260 | 0 | 0 | 3.02 | 3.02 | 3.02 | 10208 | 3.02 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions